Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
DomainYEATS

MLLT1 MLLT3

6.27e-054612IPR005033
DomainYEATS

MLLT1 MLLT3

6.27e-054612PS51037
DomainYEATS

MLLT1 MLLT3

6.27e-054612PF03366
Domain-

AFAP1 AKAP13 TNS4 PLEKHA7 GAB1 NOS1AP

1.70e-033916162.30.29.30
DomainPH_dom-like

AFAP1 AKAP13 TNS4 PLEKHA7 GAB1 NOS1AP

2.62e-03426616IPR011993
DomainSANT_dom

NCOR2 ZNF541

3.24e-0326612IPR017884
DomainSANT

NCOR2 ZNF541

3.76e-0328612PS51293
DomainMyb_DNA-binding

NCOR2 ZNF541

5.83e-0335612PF00249
DomainPH

AFAP1 AKAP13 PLEKHA7 GAB1

6.65e-03229614PF00169
DomainMYB_LIKE

NCOR2 ZNF541

6.84e-0338612PS50090
Pubmed

Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.

NCOR2 EGR2 SETBP1 MDC1 SAP30BP HSH2D AKAP13 WDR90 PLEKHA7 GAB1

3.87e-09430611035044719
Pubmed

The Intrinsically Disordered Proteins MLLT3 (AF9) and MLLT1 (ENL) - Multimodal Transcriptional Switches With Roles in Normal Hematopoiesis, MLL Fusion Leukemia, and Kidney Cancer.

MLLT1 MLLT3

3.03e-06261234174329
Pubmed

An AF9/ENL-targted peptide with therapeutic potential in mixed lineage leukemias.

MLLT1 MLLT3

3.03e-06261225509985
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

NCOR2 SEMA4B HIVEP2 SLC16A5 PI4KA ANKRD11 MLLT1 AKAP13 WDR90 MAPKBP1 ARID1A

3.09e-061105611135748872
Pubmed

Reversible disruption of BCL6 repression complexes by CD40 signaling in normal and malignant B cells.

NCOR2 CD40

9.07e-06361218487509
Pubmed

Serum concentration and interaction properties of MBL/ficolin associated protein-1.

MASP1 FCN3

9.07e-06361221035894
Pubmed

The ENL moiety of the childhood leukemia-associated MLL-ENL oncoprotein recruits human Polycomb 3.

MLLT1 MLLT3

9.07e-06361211313972
Pubmed

Activation of the lectin complement pathway by H-ficolin (Hakata antigen).

MASP1 FCN3

9.07e-06361211907111
Pubmed

Crystal structure and functional characterization of the complement regulator mannose-binding lectin (MBL)/ficolin-associated protein-1 (MAP-1).

MASP1 FCN3

9.07e-06361222854970
Pubmed

Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.

CCDC14 NCOR2 CENPC PI4KA CUL7 ARID1A PLEKHA7 PTPRT GAB1 NOS1AP

1.33e-051049611027880917
Pubmed

Importance of a specific amino acid pairing for murine MLL leukemias driven by MLLT1/3 or AFF1/4.

MLLT1 MLLT3

1.81e-05461225282333
Pubmed

MBL-associated serine protease-3 circulates in high serum concentrations predominantly in complex with Ficolin-3 and regulates Ficolin-3 mediated complement activation.

MASP1 FCN3

1.81e-05461219939495
Pubmed

Co-complexes of MASP-1 and MASP-2 associated with the soluble pattern-recognition molecules drive lectin pathway activation in a manner inhibitable by MAp44.

MASP1 FCN3

1.81e-05461223785123
Pubmed

Gab1 and Mapk Signaling Are Essential in the Hair Cycle and Hair Follicle Stem Cell Quiescence.

EGR2 GAB1

1.81e-05461226456821
Pubmed

Mll fusions generated by Cre-loxP-mediated de novo translocations can induce lineage reassignment in tumorigenesis.

MLLT1 MLLT3

1.81e-05461216096649
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

HIVEP2 MYLK3 SLF2 PI4KA ANKRD11 AKAP13 PLEKHA7 GAB1 NOS1AP

1.84e-0586161936931259
Pubmed

Nicotinic receptors regulate B lymphocyte activation and immune response.

CD40 CHRNA4

3.02e-05561215963492
Pubmed

KCTD19 and its associated protein ZFP541 are independently essential for meiosis in male mice.

CENPC ZNF541

4.52e-05661233961623
Pubmed

Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma.

POU2F2 ARID1A

6.32e-05761224435047
Pubmed

Human Polymerase-Associated Factor complex (PAFc) connects the Super Elongation Complex (SEC) to RNA polymerase II on chromatin.

MLLT1 MLLT3

8.42e-05861221873227
Pubmed

Linking H3K79 trimethylation to Wnt signaling through a novel Dot1-containing complex (DotCom).

MLLT1 MLLT3

8.42e-05861220203130
Pubmed

The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals.

CD40 CR2

1.08e-04961219494269
Pubmed

A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription.

MLLT1 MLLT3

1.35e-041061220153263
Pubmed

Myelin transcription factor 1 (Myt1) of the oligodendrocyte lineage, along with a closely related CCHC zinc finger, is expressed in developing neurons in the mammalian central nervous system.

MYT1L CD40

1.35e-04106129373037
Pubmed

BCoR, a novel corepressor involved in BCL-6 repression.

NCOR2 MLLT3

1.35e-041061210898795
Pubmed

Novel SWI/SNF chromatin-remodeling complexes contain a mixed-lineage leukemia chromosomal translocation partner.

MLLT1 ARID1A

1.35e-041061212665591
Pubmed

Human ALKBH4 interacts with proteins associated with transcription.

MLLT1 MLLT3

1.35e-041061223145062
Pubmed

Expression of Leukaemia associated transcription factor Af9/Mllt3 in the cerebral cortex of the mouse.

MLLT1 MLLT3

1.35e-041061219000783
Pubmed

HIV-1 Tat assembles a multifunctional transcription elongation complex and stably associates with the 7SK snRNP.

MLLT1 MLLT3

1.65e-041161220471949
Pubmed

HDAC3 ensures stepwise epidermal stratification via NCoR/SMRT-reliant mechanisms independent of its histone deacetylase activity.

NCOR2 SPRR1B

1.65e-041161232467224
Pubmed

A census of human transcription factors: function, expression and evolution.

MYT1L HIVEP2 EGR2 SETBP1 MLLT1 MLLT3 POU2F2 ZNF541

1.81e-0490861819274049
Pubmed

The little elongation complex regulates small nuclear RNA transcription.

MLLT1 MLLT3

1.97e-041261222195968
Pubmed

The SWI/SNF BAF-A complex is essential for neural crest development.

EGR2 ARID1A

2.33e-041361226806701
Pubmed

Transcriptional and posttranscriptional regulation of HIV-1 gene expression.

MLLT1 MLLT3

2.33e-041361222355797
Pubmed

The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.

NCOR2 CENPC SLF2 MDC1 SAP30BP ANKRD11 MLLT1 ARID1A

2.53e-0495461836373674
Pubmed

Thirteen genes (Cebpb, E2f1, Tcf4, Cyp24, Pck1, Acra4, Edn3, Kcnb1, Mc3r, Ntsr, Cd40, Plcg1 and Rcad) that probably lie in the distal imprinting region of mouse chromosome 2 are not monoallelically expressed.

CD40 CHRNA4

2.72e-04146127781998
Pubmed

MLL-AF9 and MLL-ENL alter the dynamic association of transcriptional regulators with genes critical for leukemia.

MLLT1 MLLT3

2.72e-041461220854876
Pubmed

Enhanced prediction of Src homology 2 (SH2) domain binding potentials using a fluorescence polarization-derived c-Met, c-Kit, ErbB, and androgen receptor interactome.

HSH2D TNS4 GAB1

2.93e-047361324728074
Pubmed

Interaction network of human early embryonic transcription factors.

NCOR2 HIVEP2 EGR2 MDC1 ARID1A

3.81e-0435161538297188
Pubmed

Oct4 links multiple epigenetic pathways to the pluripotency network.

NCOR2 MDC1 SAP30BP ARID1A

4.53e-0420361422083510
Pubmed

The leukemogenic AF4-MLL fusion protein causes P-TEFb kinase activation and altered epigenetic signatures.

MLLT1 MLLT3

4.55e-041861221030982
Pubmed

Effect of expression alteration in flanking genes on phenotypes of St8sia2-deficient mice.

AKAP13 AGBL1

4.55e-041861231541165
Pubmed

Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains.

CENPC MDC1

5.08e-041961214578343
Pubmed

Lost in transcription: molecular mechanisms that control HIV latency.

MLLT1 MLLT3

5.08e-041961223518577
Pubmed

Identification and developmental analysis of genes expressed by dopaminergic neurons of the substantia nigra pars compacta.

USP6 PI4KA PTPRT

5.41e-049061315033168
Pubmed

HIV-1 Tat and host AFF4 recruit two transcription elongation factors into a bifunctional complex for coordinated activation of HIV-1 transcription.

MLLT1 MLLT3

5.63e-042061220471948
Pubmed

Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.

NCOR2 SLF2 PI4KA CUL7 ARID1A GAB1

5.75e-0458861638580884
Pubmed

Corepressor SMRT is required to maintain Hox transcriptional memory during somitogenesis.

NCOR2 EGR2

6.22e-042161230254164
Pubmed

The Role of RNA Polymerase II Elongation Control in HIV-1 Gene Expression, Replication, and Latency.

MLLT1 MLLT3

6.83e-042261222567366
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

NCOR2 SAP30BP MLLT1 CUL7 ARID1A AGBL1 SLC4A11 NOS1AP

7.15e-04111661831753913
Pubmed

New insights into the control of HIV-1 transcription: when Tat meets the 7SK snRNP and super elongation complex (SEC).

MLLT1 MLLT3

7.48e-042361221360054
Pubmed

Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.

KATNIP MAPKBP1 ADAMTSL3

8.47e-041056139628581
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

NCOR2 HIVEP2 SPATA6 SETBP1 ANKRD11 AKAP13 KATNIP VPS54 ARID1A

1.10e-03148961928611215
Pubmed

Mammalian SWI/SNF collaborates with a polycomb-associated protein to regulate male germline transcription in the mouse.

MDC1 ARID1A

1.28e-033061231043422
Pubmed

Association between the SERPING1 gene and age-related macular degeneration: a two-stage case-control study.

MASP1 CR2

1.45e-033261218842294
CytobandEnsembl 112 genes in cytogenetic band chr15q25

AKAP13 ANKRD34C ADAMTSL3 AGBL1

6.35e-05160614chr15q25
GeneFamilySuper elongation complex|YEATS domain containing

MLLT1 MLLT3

2.71e-0543921283
GeneFamilyAF4/FMR2 family|Super elongation complex

MLLT1 MLLT3

1.62e-0493921280
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

AFAP1 AKAP13 PLEKHA7 GAB1

9.85e-04206394682
GeneFamilyGATA zinc finger domain containing|Myb/SANT domain containing

NCOR2 ZNF541

5.83e-0353392532
GeneFamilyHyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing

MASP1 CR2

6.71e-03573921179
CoexpressionAtlasalpha beta T cells, T.4+8int.Th, 4+ 8int TCRhi, Thymus, avg-3

AFAP1 HIVEP2 SPATA6 SLC16A5 EGR2 MLLT3 TESPA1

2.48e-05302617GSM399362_500
ToppCellB_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis

CACNA1A SEMA4B SETBP1 CD40 HSH2D POU2F2 CR2

8.91e-0919461722b87fe2bb84632ddcef8f1d7742021728e2246d
ToppCell3'-Child09-12-SmallIntestine-Hematopoietic-B_cells-FCRL4+_Memory_B|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

EGR2 SETBP1 CD40 HSH2D POU2F2 CR2

1.99e-0718461695cf125127658c4c04445c61809d1aed21ee1f83
ToppCellPBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SEMA4B SETBP1 CD40 POU2F2 CR2 CCDC85A

2.55e-0719261689b8ebdc285ed3c0f807fd1157271130d37dfa41
ToppCellB_cells-Activate_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis

CACNA1A SEMA4B SETBP1 CD40 POU2F2 CR2

2.63e-07193616b6da81920cf2e55f87ec8d4b2b5530cbf7ba2155
ToppCellcontrol-B_intermediate|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

SEMA4B SETBP1 CD40 POU2F2 CR2 CCDC85A

2.79e-07195616ddbc924b1a08685da0ed0755856178bae99a75b9
ToppCellcontrol-B_intermediate|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

SEMA4B SETBP1 CD40 POU2F2 CR2 CCDC85A

3.06e-07198616e24345c8cec8c21f7b5163b7326ba8f83a587ce3
ToppCellCOVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type

MYT1L CACNA1A MUC16 AGBL1 PTPRT

1.36e-0613961564c35411bbe67acb5010dadc4b0b1be0f8b17737
ToppCellCOVID-19-kidney-Technical/muscle|kidney / Disease (COVID-19 only), tissue and cell type

MYT1L CACNA1A ANKRD34C AGBL1 PTPRT

1.85e-061486150dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e
ToppCellPND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SEMA4B STAC2 POU2F2 CR2 TESPA1

2.10e-06152615b750302d442160a1007659c2386ac90282bf95d2
ToppCelldroplet-Lung-immune-endo-depleted-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CCDC14 SEMA4B STAC2 CR2 TESPA1

2.62e-0615961574655c22e9fdd88e3052b9dfb954c8fb678bd2d8
ToppCellPBMC-Severe-Lymphocyte-B-B_cell-B_memory-B_memory-6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SEMA4B SETBP1 CD40 HSH2D POU2F2

4.19e-06175615eaec7fda07a9537d067ca13b607a8ab201caa7c4
ToppCellfacs-Liver-Liver_non-hepato/SCs_st-18m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD40 HSH2D POU2F2 CR2 SLC4A11

4.31e-061766150f056597bc9e53176ce8670924ac925c801964b5
ToppCellfacs-Liver-Liver_non-hepato/SCs_st-18m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD40 HSH2D POU2F2 CR2 SLC4A11

4.31e-06176615d04be5acf0be46adc3d2055f6f21358c02792817
ToppCellPBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SEMA4B CD40 POU2F2 CR2 CCDC85A

4.56e-06178615812e261d9cbdc74fafe3c5c3422151c1cfacb22d
ToppCellChildren_(3_yrs)-Immune-B_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

SEMA4B SETBP1 HSH2D POU2F2 CR2

4.81e-0618061540a12eb852373ae3d7c8d9bca376b0ae99f724b3
ToppCellCOVID-19_Moderate-B_intermediate|World / disease group, cell group and cell class

CACNA1A SEMA4B CD40 POU2F2 CR2

4.81e-06180615bd81b87a6dc81e5ab4a6c948eb0c80f14401a6a7
ToppCellmoderate-Lymphoid-B_cell|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

SETBP1 CD40 HSH2D POU2F2 CR2

5.64e-06186615fd2c4c3e8929ca5d64f6c5064e5f3d3d6ba07b5f
ToppCellfacs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYT1L CACNA1A HIVEP2 POU2F2 NOS1AP

5.64e-061866157278a1a1bf9bb27aeb03852134defb31b62f30d6
ToppCellControl-Lymphocyte-B-B_intermediate|Control / Disease, Lineage and Cell Type

SEMA4B CD40 POU2F2 CR2 CCDC85A

5.79e-0618761590c9b1a51539838323325f563be4adf5fdf1b38f
ToppCellMultiple_Sclerosis-Lymphocyte-B-B_memory|Multiple_Sclerosis / Disease, Lineage and Cell Type

SEMA4B SETBP1 CD40 HSH2D POU2F2

5.94e-061886158da631b2c75441b7309f03e7d4c14f15f2367be6
ToppCellMultiple_Sclerosis-Lymphocyte-B-B_intermediate|Multiple_Sclerosis / Disease, Lineage and Cell Type

SEMA4B SETBP1 CD40 POU2F2 CCDC85A

5.94e-06188615ee1bb0700ab70e03a63982446a33976b9200ddb6
ToppCellNS-moderate-d_07-13-Lymphoid-B_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

SETBP1 CD40 HSH2D POU2F2 CR2

5.94e-06188615e9ed34cfea1d93eaa8e63d5b5dbb64f1520d9c4c
ToppCellCOVID_vent-Lymphocytic-B_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass

SEMA4B SETBP1 CD40 POU2F2 CR2

6.26e-0619061540b5e9e8f8fd8d84cb5b43e67b49267082348e9f
ToppCellCOVID_vent-Lymphocytic-B_cell-|COVID_vent / Disease condition, Lineage, Cell class and subclass

SEMA4B SETBP1 CD40 POU2F2 CR2

6.26e-06190615a37a32dc1b931562a6660074e19d5598efc65284
ToppCell10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

SETBP1 CD40 POU2F2 CR2 GAB1

6.26e-06190615a7498fe55b7810c482291db782dc5282675d246a
ToppCellControl-Lymphoid_B-B_intermediate|Control / Disease group, lineage and cell class

SEMA4B SETBP1 CD40 POU2F2 CR2

6.42e-061916150082181dbc39c7c4fd3aa34c3ed61439548e844b
ToppCellPBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SEMA4B SETBP1 CD40 POU2F2 CR2

6.42e-061916155a9a592875fbd0b1429b48db29a760fdc9c2c856
ToppCellCOVID-19_Severe-B_intermediate|World / disease group, cell group and cell class

CACNA1A SEMA4B CD40 POU2F2 PTPRT

6.42e-06191615f226fd69a26124ba98e4544f550b89a08e6a3708
ToppCell10x5'-bone_marrow-Lymphocytic_B-Naive_B_cells|bone_marrow / Manually curated celltypes from each tissue

SEMA4B CD40 POU2F2 CR2 GAB1

6.58e-06192615fa99243ff028498c6a67d207a93e02c48e69cd42
ToppCellPBMC-Control-Lymphocyte-B-B_cell-B_intermediate-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

SEMA4B SETBP1 CD40 POU2F2 CR2

6.58e-06192615f9f64ad7bab1433e9a45adb7db7f43ce3f591b47
ToppCellPBMC-Control-Lymphocyte-B-B_cell-B_intermediate|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

SEMA4B SETBP1 CD40 POU2F2 CR2

6.58e-061926154884fd8ffa6fd6c30d7ac6bf447456b3397eabc5
ToppCellmoderate-Lymphoid-B_cell|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

SETBP1 CD40 HSH2D POU2F2 CR2

6.58e-06192615ae3727503c3b9f4695e565fd3161cc33b898f349
ToppCellPBMC-Control-Lymphocyte-B-B_cell-B_intermediate|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SEMA4B SETBP1 CD40 POU2F2 CR2

6.75e-061936158f1d6024ef092923321e6efd441b8d476db70aed
ToppCellCOVID_non-vent-Lymphocytic-B_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

SEMA4B SETBP1 CD40 POU2F2 CR2

6.75e-0619361532d139f922cd19adc1cc1e0e9a828115be9945d6
ToppCellCOVID_non-vent-Lymphocytic-B_cell-|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

SEMA4B SETBP1 CD40 POU2F2 CR2

6.75e-0619361591955c3773c9729a96e82f240f06b072367970d9
ToppCellMS-naiveBc|MS / Condition, Cell_class and T cell subcluster

SEMA4B SETBP1 CD40 HSH2D POU2F2

6.92e-06194615aa4aa0a61275610054b583f60d5d41ecc4f88a0d
ToppCellremission-B_intermediate|World / disease stage, cell group and cell class

SEMA4B CD40 POU2F2 CR2 CCDC85A

6.92e-0619461578556b60c84c7bbffa1c8bf8684b3c427512da44
ToppCellCOVID-19_Mild-Lymphoid_B-B_intermediate|COVID-19_Mild / Disease group, lineage and cell class

SEMA4B SETBP1 CD40 POU2F2 CR2

6.92e-06194615bf6f72a489c62cbf1a679552d8c5eaaaa0b99d33
ToppCellPBMC-Severe-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-6|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SEMA4B SETBP1 CD40 HSH2D POU2F2

6.92e-061946152b5eee7c3e52b63cce94205d18133c7704329c02
ToppCell10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-B_lymphocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

SETBP1 CD40 HSH2D POU2F2 CR2

6.92e-061946159b134a6e51b8556a04c362967fa474f8a7f59920
ToppCellMS-naiveBc-|MS / Condition, Cell_class and T cell subcluster

SEMA4B SETBP1 CD40 HSH2D POU2F2

6.92e-061946151757787246a7862f9709834efc62bac61d70b906
ToppCellSmart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

MYT1L CACNA1A MUC16 AGBL1 PTPRT

7.10e-06195615d3755929ebbbf5e3afde44281e9056ddb614a291
ToppCell10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-B_lymphocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

SETBP1 CD40 HSH2D POU2F2 GAB1

7.10e-061956156da69e3eba036936f44bc052996ad12b6309055e
ToppCell10x5'-lymph-node_spleen-Lymphocytic_B-Memory_B_cells|lymph-node_spleen / Manually curated celltypes from each tissue

SETBP1 CD40 HSH2D POU2F2 CR2

7.10e-061956158b307079cee67fc1df55277d0cab21ea4b97e552
ToppCellSmart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

MYT1L CACNA1A MUC16 AGBL1 PTPRT

7.10e-0619561519853c654ac64b3ae3bc99841c6cb29c8aaba85c
ToppCellcontrol-Lymphocytic-B_cells_1|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

SEMA4B SETBP1 CD40 POU2F2 CR2

7.10e-06195615ff7956624b36df34e55295b295a71585accf07bd
ToppCellsevere-B_cell|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

CD40 POU2F2 WEE2 CR2 GAB1

7.10e-061956150fc3c605609c9e6bdea15d73c45def2188ae5fb1
ToppCellHealthy-B_intermediate|World / disease group, cell group and cell class

SEMA4B SETBP1 CD40 POU2F2 PTPRT

7.10e-061956159de79e0bdd9063ae65e5edb89cc3fe6f9a8173bc
ToppCellCOVID-19_Severe-Lymphoid_B|COVID-19_Severe / Disease group, lineage and cell class

SEMA4B SETBP1 CD40 POU2F2 CR2

7.46e-0619761525303329b051831cf2ed4df68f3948308e5fbd96
ToppCellBronchus_Control_(B.)|World / Sample group, Lineage and Cell type

HIVEP2 SPRR1B MUC16 ATP10B TNS4

7.46e-06197615b6dff2ee108813e18657e2d8cf850e2423f8c8e9
ToppCellmLN-(2)_B_cell-(22)_B_cell_memory|mLN / shred on region, Cell_type, and subtype

SETBP1 CD40 HSH2D POU2F2 CR2

7.64e-061986154d189df1db5b41306e9653436d7d7e75ff5afa06
ToppCellmLN-B_cell-B_cell_memory|mLN / Region, Cell class and subclass

SETBP1 CD40 HSH2D POU2F2 CR2

7.64e-061986156dc155ee487abb1319a60a7a70e84c28c9851985
ToppCellCOVID-19-COVID-19_Mild-Lymphocyte-B-B_intermediate|COVID-19_Mild / Disease, condition lineage and cell class

SEMA4B SETBP1 CD40 POU2F2 CR2

7.83e-061996151c6a08d01f6c1a2a4b6587d3a4522efbd03275e1
ToppCellmLN-B_cell|mLN / Region, Cell class and subclass

SETBP1 CD40 HSH2D POU2F2 CR2

7.83e-0619961599c7d157a1e819ff86c526ffd9b7036ed3514cae
ToppCellControl-Control-Lymphocyte-B-B_intermediate|Control / Disease, condition lineage and cell class

SEMA4B SETBP1 CD40 POU2F2 CR2

7.83e-06199615ee6f07eec7edfe41d2f7fcb0b509ce00e99a6a95
ToppCellCOVID-19-COVID-19_Severe-Lymphocyte-B-B_memory|COVID-19_Severe / Disease, condition lineage and cell class

SEMA4B SETBP1 CD40 HSH2D POU2F2

7.83e-0619961524c05faa825c9d55279956469862440f9914a280
ToppCellMS-Multiple_Sclerosis-Lymphocyte-B-B_memory|Multiple_Sclerosis / Disease, condition lineage and cell class

SEMA4B SETBP1 CD40 HSH2D POU2F2

7.83e-06199615ae2979c0d2711580863d3b751f6ff1e3abdfd90e
ToppCell10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-B_lymphocytic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

SETBP1 CD40 HSH2D POU2F2 CR2

7.83e-061996151aa963ed5205d6d52262b1597a5d08707a95c3ca
ToppCellmLN-(2)_B_cell|mLN / shred on region, Cell_type, and subtype

SETBP1 CD40 HSH2D POU2F2 CR2

7.83e-061996159464c8c72a6b2e14a27b413cc1f5d64550212776
ToppCellCOVID-19-COVID-19_Convalescent-Lymphocyte-B-B_intermediate|COVID-19_Convalescent / Disease, condition lineage and cell class

SEMA4B CD40 POU2F2 CR2 CCDC85A

8.02e-06200615fdc0df661a34e0db3279334bdeebfdf60c85ef41
ToppCellmild-B_intermediate|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

SEMA4B SETBP1 CD40 POU2F2 CR2

8.02e-06200615fe815824e9e4be3f3db73610e3814a7fd533da65
ToppCellmild-B_intermediate|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

SEMA4B SETBP1 CD40 POU2F2 CR2

8.02e-062006158e3132a1fe3708f725c5c4077878fb87bbea3678
ToppCellMS-Multiple_Sclerosis-Lymphocyte-B-B_intermediate|Multiple_Sclerosis / Disease, condition lineage and cell class

SEMA4B SETBP1 CD40 POU2F2 CCDC85A

8.02e-06200615e945dd467dc90b8042982051d1bf76b72a4baf5b
ToppCellHippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6|Hippocampus / BrainAtlas - Mouse McCarroll V32

EGR2 ATP10B ANKRD34C PLEKHA7

1.76e-051136146f270b7e59c18243e876311df721e948ce21e850
ToppCellControl-B_activate-7|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)

DGLUCY EGR2 SLF2 WDR90

1.89e-05115614cc2f8fb0cbb72b241b65a69195aac0507bddf2e2
ToppCellControl-Classical_Monocyte-|Classical_Monocyte / Disease condition and Cell class

HIVEP2 MYLK3 CD40 PFKFB3

3.06e-051306144433b40b099845f113993b6ecf85ec594b4b9219
ToppCellCOVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type

MYT1L CACNA1A AGBL1 PTPRT

4.81e-05146614c55f1bdb6ac43b4118cb27ea7c879527e1afcbab
ToppCellCOVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type

MYT1L CACNA1A AGBL1 PTPRT

5.07e-05148614d6ac5972267254651dfbe16bb4e9a62228093cc7
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D175|Adult / Lineage, Cell type, age group and donor

STAC2 ATP10B AGBL1 NOS1AP

5.34e-05150614b0b6ba3686d3eb8a9b249d30be14111de3b893be
ToppCellPND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

STAC2 POU2F2 AGBL1 SLC4A11

5.34e-05150614d6b977dd47aa017f6ba762f0c505cd896caa523f
ToppCellCOVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type

MYT1L CACNA1A AGBL1 PTPRT

5.34e-051506140205318a870e091add66ee4305747dda9f51510d
ToppCellPND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SEMA4B STAC2 POU2F2 TESPA1

5.48e-05151614ee56b88c56c3b6a5ec9644c43cae521ea0e05920
ToppCellPND01-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SEMA4B STAC2 POU2F2 TESPA1

5.48e-051516142c239b09970acbaa90c5ebe1097f453c516f868e
ToppCellEntopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Spp1_(Entopeduncular_Nucleus_(Ent)_or_Zona_Incerta,_ventral_part_(ZIV)._State_signal?)|Entopeduncular / BrainAtlas - Mouse McCarroll V32

CSF2RB CR2 ZNF541

5.60e-055461398b31718fa200432cf86b59a52484da101219f96
ToppCellEntopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Spp1_(Entopeduncular_Nucleus_(Ent)_or_Zona_Incerta,_ventral_part_(ZIV)._State_signal?)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32

CSF2RB CR2 ZNF541

5.60e-0554613872e7374dac64be2c8ebe71e88a2ec6814168d89
ToppCellPND03-Immune-Immune_Myeloid-DC-maDC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DGLUCY CSF2RB HSH2D PFKFB3

6.22e-05156614095281ea78aefa0ee638191a03f8d6f62a86a9ff
ToppCellPND03-Immune-Immune_Myeloid-DC-maDC-maDC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DGLUCY CSF2RB HSH2D PFKFB3

6.22e-0515661429b04143f71a0ecc600ac670abd1d521bee55fe7
ToppCellCOVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type

MYT1L CACNA1A AGBL1 PTPRT

6.70e-051596145335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCellPND07-Immune-Immune_Myeloid-DC-maDC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CSF2RB HSH2D WDR90 PFKFB3

6.86e-051606147db30647b596f0c419087e6fabb9b99dcd5bddd4
ToppCellPND07-Immune-Immune_Myeloid-DC-maDC-maDC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CSF2RB HSH2D WDR90 PFKFB3

6.86e-0516061401f22cdb2a2f73776b7f91746e95c1850df94235
ToppCellnucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Suprabasal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

SPRR1B MUC16 TNS4 SLC4A11

7.20e-05162614112fa4de685727f6c8bf6fc4afb82de0524070ad
ToppCell390C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)

HSH2D POU2F2 FCN3 CCDC85A

7.20e-0516261445be019b50e3727fc9d3fad2ff78e74e4f2d746b
ToppCell390C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)

HSH2D POU2F2 FCN3 CCDC85A

7.20e-05162614fbb0cc2b1434a340dc35058b77c73ea61004c252
ToppCellCOVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type

MYT1L CACNA1A AGBL1 PTPRT

7.38e-0516361419c28ce16a588a7f4a035c32726f6ccd67702b5b
ToppCell3'_v3-bone_marrow-Lymphocytic_B-ABC_aged-B_memory|bone_marrow / Manually curated celltypes from each tissue

SEMA4B CD40 MUC16 POU2F2

7.38e-0516361430f5c93c4e170304d701b5231f0d545f404066f7
ToppCellfacs-Lung-24m-Hematologic-lymphocytic-plasma_cell-plasma_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

SEMA4B STAC2 SLC16A5 CENPC

7.92e-05166614139bf49eb3624d9eec7e8a2cb33d69716d63a7c5
ToppCellfacs-Lung-24m-Hematologic-lymphocytic-plasma_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

SEMA4B STAC2 SLC16A5 CENPC

7.92e-0516661485f59c3cc7db8863ec0044f1fcc14580834f830b
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MYT1L CACNA1A AGBL1 PTPRT

8.10e-051676143edb0570e583bb527165bcd8a4c25a042054043b
ToppCellfacs-Lung-EPCAM-24m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SEMA4B DGLUCY CSF2RB TESPA1

8.10e-05167614e0f2509e86302eca8352821bce12597f6c51fc24
ToppCellfacs-Lung-EPCAM-24m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SEMA4B DGLUCY CSF2RB TESPA1

8.10e-05167614b25646b6653cd8814dbeae4c74ce899ede105200
ToppCell5'-Adult-Appendix-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CD40 MUC16 CR2 SLC4A11

8.10e-051676148b223333c0c7a85b5a1af6f2f5b12ee0d94357f6
ToppCell10x5'v1-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-eosinophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

CSF2RB HSH2D TNS4 TESPA1

8.48e-05169614f68195510b91e287fe1507455ca067ece77a3897
ToppCell390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)

HIVEP2 STON1 SLF2 TNS4

8.68e-05170614a6fa0cab1fa829ec601fe48306b4c43c83425b04
ToppCell390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)

HIVEP2 STON1 SLF2 TNS4

8.68e-05170614b40255eee45eb18b5a297336d7f3845fd8f8aa3b
ToppCellfacs-Trachea-18m-Hematologic-myeloid-granulocyte-granulocyte_l26|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CCDC14 CSF2RB MAPKBP1 TESPA1

8.68e-051706144b1c84b35b7242a297ffdb9c23a6d982acf1bed5
ToppCellChildren_(3_yrs)-Immune-B_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

SETBP1 HSH2D POU2F2 CR2

8.68e-05170614e421f9eedf74baffda1d03707a710ece4b777f29
ToppCellAdult-Immune-B_cell-D175|Adult / Lineage, Cell type, age group and donor

SETBP1 HSH2D POU2F2 CR2

8.88e-05171614355a246f3395900342d400f6f7c6640cba0d4d5d
ToppCellCOVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type

MYT1L CACNA1A AGBL1 PTPRT

8.88e-05171614b2e753e811a7639956994609f73efcdb62d04f82
ToppCell5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CD40 HSH2D POU2F2 CR2

9.08e-05172614172e3c78f8e97988a4fd8624514e731282ddc16d
ToppCell3'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells-Immature_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CD40 HSH2D POU2F2 CR2

9.08e-051726140bcb960c5ab0d3cbbdf6235b6f28327ea60ba3e3
DiseaseFuchs Endothelial Dystrophy

AGBL1 SLC4A11

4.05e-055602C0016781
DiseaseFuchs' endothelial dystrophy (is_implicated_in)

AGBL1 SLC4A11

6.07e-056602DOID:11555 (is_implicated_in)
Diseaseresponse to fluoroquinolones, drug-induced liver injury

CCDC14 CCDC85A

6.07e-056602EFO_0004228, EFO_0007920
Diseaselean body mass

NCOR2 HIVEP2 SLF2 AKAP13 MAPKBP1 ADAMTSL3

1.20e-04379606EFO_0004995
Diseaseasthma

HIVEP2 ANKRD11 MUC16 MLLT3 ATP10B ADAMTSL3 TESPA1 GAB1

1.35e-04751608MONDO_0004979
Diseasepro‐interleukin‐16 measurement

MLLT3 ADAMTSL3

2.21e-0411602EFO_0010629
Diseasewhite matter hyperintensity measurement

NCOR2 STON1 SETBP1 ARID1A CCDC85A

3.74e-04302605EFO_0005665
DiseaseSchizophrenia

MYT1L CSF2RB EGR2 PI4KA SAP30BP ADAMTSL3 CHRNA4 NOS1AP

4.02e-04883608C0036341
Diseasemannan-binding lectin serine protease 1 measurement

MASP1 FCN3

4.20e-0415602EFO_0008223
DiseaseIschemic stroke

STON1 SETBP1 ADAMTSL3 AGBL1 PTPRT

5.16e-04324605HP_0002140
DiseaseNeurodevelopmental Disorders

MYT1L SETBP1 ANKRD11

9.11e-0493603C1535926
Diseaseupper face morphology measurement

MLLT3 PLEKHA7 SLC4A11

1.03e-0397603EFO_0010949
Diseasesmoking behaviour measurement

CD40 PLEKHA7 CHRNA4 NOS1AP

1.09e-03222604EFO_0005671
Diseasespontaneous preterm birth

MYT1L SPATA6 PFKFB3

1.16e-03101603EFO_0006917
Diseasecortical surface area measurement

CACNA1A AFAP1 STON1 MDC1 MLLT3 ADAMTSL3 PLEKHA7 AGBL1 C17orf58

1.50e-031345609EFO_0010736
DiseaseBilateral Wilms Tumor

MLLT1 ARID1A

1.59e-0329602C2930471
Diseasewaist circumference

SETBP1 MLLT3 ADAMTSL3 PTPRT C17orf58

1.80e-03429605EFO_0004342

Protein segments in the cluster

PeptideGeneStartEntry
RKPDHTTVDIPPACP

CACNA1A

1161

O00555
EAEKASPHPSPGPCR

CHRNA4

436

P43681
PPSPKVEDRHSPPLC

ANKRD34C

171

P0C6C1
HCPPAAVVTVTPSPE

ANKRD11

1866

Q6UB99
PDCLEVKELTPHPSG

GJD2

166

Q9UKL4
HESFPRPKRVCKDPP

MLLT3

56

P42568
DSECPPPPSSPVHKA

AFAP1

256

Q8N556
TPLPEDCSPTHSPRV

AKAP13

2391

Q12802
QRPPCPPKVHSEVQT

CCDC14

266

Q49A88
PHCPSETTPLLSPEK

ATP10B

21

O94823
VPGCITTEPPHDLPE

AGBL1

286

Q96MI9
SKTPVHERPYPCPAE

EGR2

331

P11161
SKTELLPSRPHAPCP

ARID1A

1861

O14497
HAPCPPAPRKHVTTA

ARID1A

1871

O14497
VSHLCPEPPETRVSP

FAM47C

351

Q5HY64
PEAGVSHLCPEPPKT

FAM47C

371

Q5HY64
LRPEPPDTGVSHLCP

FAM47C

486

Q5HY64
PDTGVSHLCPEPPKT

FAM47C

491

Q5HY64
RPEPPDTGVSHLCPE

FAM47C

571

Q5HY64
DTGVSHLCPEPPKTR

FAM47C

576

Q5HY64
HLCPEPPKTRVSSLP

FAM47C

581

Q5HY64
PPKTRVSSLHAEPPE

FAM47C

706

Q5HY64
AEPPESRVSHLCPEP

FAM47C

716

Q5HY64
LCPEPPETGVSHLRP

FAM47C

726

Q5HY64
HPSCPGPRELEASKV

FCN3

26

O75636
VDAVCTHRPDPKSPG

MUC16

13391

Q8WXI7
VHEPPREDAAPTKPA

NCOR2

981

Q9Y618
PIDHKPCSAPLEPKS

MDC1

1736

Q14676
PKPHPAHDRSPVETC

GAB1

346

Q13480
ATSPPVKCPPVHEEP

KATNIP

716

O60303
SPEAPVAERKTSPPH

C17orf58

16

Q2M2W7
SPPEASPIKPALTCH

KIAA2026

1041

Q5HYC2
PAPPAPFEHRVVSVK

MYLK3

491

Q32MK0
VHVEPCEAPPPVVAT

CUL7

1101

Q14999
PVDHRPSLPRSCGPK

PFKFB3

16

Q16875
KCLEPPSHPEEPSDL

POU2F2

186

P09086
EASQPKPCPPEVTPH

PI4KA

1281

P42356
CPVSAPEEASPKPVL

HSH2D

151

Q96JZ2
PLTTRTKCADPVHGP

PTPRT

376

O14522
PLTIEDPKHVCDPPS

CSF2RB

536

P32927
DPKHVCDPPSGPDTT

CSF2RB

541

P32927
RSPPVTRCPNPEVKH

CR2

781

P20023
APPHSCPPDDTKLIE

CENPC

286

Q03188
PEHPQKPRACGTPDR

CCDC85A

256

Q96PX6
CPELQPPVHGKIEPS

MASP1

301

P48740
TTPKPRTECQAHPGP

MAPKBP1

1351

O60336
SPECCHVKPAIQEPP

GCNA

106

Q96QF7
HDSFPKPRRVCKEPP

MLLT1

56

Q03111
APPGCLTPERIPEVH

DGLUCY

261

Q7Z3D6
PVLCDPTTPKPEDLH

NOS1AP

386

O75052
TVSLPAHRHPEPPKC

SLC4A11

306

Q8NBS3
QVRPHSDAKVPPASP

TMEM191B

221

P0C7N4
VHPKTCPVVLPPETR

SEMA4B

756

Q9NPR2
RPHTPAERVTVKPPD

PLEKHA7

586

Q6IQ23
EVVPCIPSPAAPSDK

SLF2

561

Q8IX21
RELPGVHPEPCPSLT

WDR90

921

Q96KV7
PVATSVAPETKECPP

SLC16A5

191

O15375
SCTHPTPKVGLPDEV

STON1

141

Q9Y6Q2
PPLAKEHASSCPPSI

TNS4

351

Q8IZW8
HPKVPEPCPSIVTPA

SPRR1B

66

P22528
PLLVHEPPPVCATSK

STAC2

176

Q6ZMT1
EIKIPPEPPGRCSNH

SAP30BP

116

Q9UHR5
PKVPCCTHSLPIEDP

TESPA1

386

A2RU30
LRTPVSHPLKCPETP

WEE2

81

P0C1S8
SHPLKCPETPAQPDS

WEE2

86

P0C1S8
PCPHPAEVPEVRSKS

HIVEP2

1036

P31629
PPTCTDHSPSRKLPE

SETBP1

506

Q9Y6X0
IKHPRPVSSQPDVPA

SETBP1

746

Q9Y6X0
TDKPPFVIRHVDPPS

SPATA6

251

Q9NWH7
VPRDPALCQHKPLTP

USP6

1111

P35125
TAVHPEPPTACREKQ

CD40

16

P25942
PSKHIRPVPSLPDVC

VPS54

26

Q9P1Q0
EKVPCSPRERPSHHP

ZNF541

1236

Q9H0D2
TPAPPEECRDEKPHA

ADAMTSL3

736

P82987
SLSGCPHKDRVPPEI

MYT1L

526

Q9UL68